249 related articles for article (PubMed ID: 36527535)
1. The Role of Multimodality Cardiac Imaging in Patients Undergoing Cancer Treatment.
Wengrofsky P; Feldman S
Curr Cardiol Rep; 2023 Jan; 25(1):1-8. PubMed ID: 36527535
[TBL] [Abstract][Full Text] [Related]
2. Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methods.
Soufer A; Liu C; Henry ML; Baldassarre LA
J Nucl Cardiol; 2020 Aug; 27(4):1210-1224. PubMed ID: 30868378
[TBL] [Abstract][Full Text] [Related]
3. Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.
Akhter N; Murtagh G; Yancy C
Future Oncol; 2015; 11(14):2093-103. PubMed ID: 26198839
[TBL] [Abstract][Full Text] [Related]
4. Advanced Imaging Modalities to Monitor for Cardiotoxicity.
Seraphim A; Westwood M; Bhuva AN; Crake T; Moon JC; Menezes LJ; Lloyd G; Ghosh AK; Slater S; Oakervee H; Manisty CH
Curr Treat Options Oncol; 2019 Aug; 20(9):73. PubMed ID: 31396720
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.
Gambril JA; Chum A; Goyal A; Ruz P; Mikrut K; Simonetti O; Dholiya H; Patel B; Addison D
Heart Fail Clin; 2022 Jul; 18(3):455-478. PubMed ID: 35718419
[TBL] [Abstract][Full Text] [Related]
6. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.
Garg V; Vorobiof G
Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436
[TBL] [Abstract][Full Text] [Related]
7. Cardiac imaging in cardiotoxicity: a focus on clinical practice.
Makavos G; Ikonomidis I; Palios J; Rigopoulos A; Katogiannis K; Parissis J; Paraskevaidis I; Noutsias M
Heart Fail Rev; 2021 Sep; 26(5):1175-1187. PubMed ID: 32306221
[TBL] [Abstract][Full Text] [Related]
8. Cardiac MRI for the evaluation of oncologic cardiotoxicity.
Löffler AI; Salerno M
J Nucl Cardiol; 2018 Dec; 25(6):2148-2158. PubMed ID: 29736616
[TBL] [Abstract][Full Text] [Related]
9. Nuclear Imaging for the Assessment of Cardiotoxicity from Chemotherapeutic Agents in Oncologic Disease.
Sreenivasan J; Hooda U; Ranjan P; Jain D
Curr Cardiol Rep; 2021 May; 23(6):65. PubMed ID: 33961140
[TBL] [Abstract][Full Text] [Related]
10. Advanced Echocardiographic Techniques in Cardio-Oncology: the Role for Early Detection of Cardiotoxicity.
Cobarro Gálvez L; Arbas Redondo E; Contreras Lorenzo C; López Fernández T
Curr Cardiol Rep; 2022 Sep; 24(9):1109-1116. PubMed ID: 35881319
[TBL] [Abstract][Full Text] [Related]
11. Advances in Screening for Radiation-Associated Cardiotoxicity in Cancer Patients.
Schiffer W; Pedersen LN; Lui M; Bergom C; Mitchell JD
Curr Cardiol Rep; 2023 Nov; 25(11):1589-1600. PubMed ID: 37796395
[TBL] [Abstract][Full Text] [Related]
12. An Update on the Role of Cardiac Magnetic Resonance Imaging in Cancer Patients.
Pons-Riverola A; Ghosh AK
Curr Cardiol Rep; 2022 Dec; 24(12):2139-2147. PubMed ID: 36342641
[TBL] [Abstract][Full Text] [Related]
13. Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies.
Biersmith MA; Tong MS; Guha A; Simonetti OP; Addison D
J Am Heart Assoc; 2020 Jan; 9(2):e013755. PubMed ID: 31960741
[No Abstract] [Full Text] [Related]
14. Cancer Therapeutics-Related Cardiac Dysfunction among Patients with Active Breast Cancer: A Cardio-Oncology Registry.
Laufer-Perl M; Mor L; Milwidsky A; Derakhshesh M; Amrami N; Moshkovits Y; Arnold J; Topilsky Y; Arbel Y; Rozenbaum Z
Isr Med Assoc J; 2020 Sep; 22(9):564-568. PubMed ID: 33236555
[TBL] [Abstract][Full Text] [Related]
15. Role of cardiovascular magnetic resonance imaging in cardio-oncology.
Saunderson CED; Plein S; Manisty CH
Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):383-396. PubMed ID: 33404058
[TBL] [Abstract][Full Text] [Related]
16. PET Tracers for Imaging Cardiac Function in Cardio-oncology.
Kelly JM; Babich JW
Curr Cardiol Rep; 2022 Mar; 24(3):247-260. PubMed ID: 35028820
[TBL] [Abstract][Full Text] [Related]
17. Cardio-oncology: the role of advanced echocardiography in cancer patients.
Venneri L; Zoppellaro G; Khattar RS
Expert Rev Cardiovasc Ther; 2018 Apr; 16(4):249-258. PubMed ID: 29457984
[TBL] [Abstract][Full Text] [Related]
18. Advanced imaging modalities to detect cardiotoxicity.
Awadalla M; Hassan MZO; Alvi RM; Neilan TG
Curr Probl Cancer; 2018 Jul; 42(4):386-396. PubMed ID: 30297038
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Imaging: Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity.
Moonen M; Oury C; Lancellotti P
Curr Oncol Rep; 2017 Aug; 19(10):63. PubMed ID: 28791609
[TBL] [Abstract][Full Text] [Related]
20. [Role of echocardiography in the detection and the monitoring of left ventricular systolic dysfunction in patients undergoing cancer therapy].
Charbonnel C
Ann Cardiol Angeiol (Paris); 2020 Nov; 69(5):255-261. PubMed ID: 32962803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
